BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cao J, Chen XP, Li WL, Xia J, Du H, Tang WB, Wang H, Chen XW, Xiao HQ, Li YY. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition. World J Gastroenterol 2007; 13(7): 1018-1026 [PMID: 17373735 DOI: 10.3748/wjg.v13.i7.1018]
URL: https://www.wjgnet.com/1007-9327/full/v13/i7/1018.htm
Number Citing Articles
1
Stephen J. Murphy, Steven N. Hart, Geoffrey C. Halling, Sarah H. Johnson, James B. Smadbeck, Travis Drucker, Joema Felipe Lima, Fariborz Rakhshan Rohakhtar, Faye R. Harris, Farhad Kosari, Subbaya Subramanian, Gloria M. Petersen, Timothy D. Wiltshire, Benjamin R. Kipp, Mark J. Truty, Robert R. McWilliams, Fergus J. Couch, George Vasmatzis. Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of DiseaseCancer Research 2016; 76(3): 749 doi: 10.1158/0008-5472.CAN-15-2198
2
Matteo Fassan, Borislav Rusev, Vincenzo Corbo, Pierluigi Gasparini, Claudio Luchini, Caterina Vicentini, Andrea Mafficini, Salvatore Paiella, Roberto Salvia, Ivana Cataldo, Aldo Scarpa, Kay Huebner. Fhit down-regulation is an early event in pancreatic carcinogenesisVirchows Archiv 2017; 470(6): 647 doi: 10.1007/s00428-017-2105-3
3
Romain Boidot, Frédérique Végran, Sarab Lizard-Nacol. Transcriptional regulation of the survivin geneMolecular Biology Reports 2014; 41(1): 233 doi: 10.1007/s11033-013-2856-0
4
Hong Li, Po Zhao, Yang Lu, Yali Lu. Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinomaInternational Journal of Colorectal Disease 2012; 27(8): 1015 doi: 10.1007/s00384-012-1421-y
5
Kim Vaiphei, Aruna Rangan, Rajinder Singh. Aberrant crypt focus and fragile histidine triad protein in sporadic colorectal carcinomaWorld Journal of Gastrointestinal Oncology 2012; 4(12): 250-258 doi: 10.4251/wjgo.v4.i12.250
6
Alfred King-Yin Lam, Said Saleh, Robert Anthony Smith, Yik-Hong Ho. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activityHuman Pathology 2008; 39(8): 1229 doi: 10.1016/j.humpath.2008.01.001
7
Rabeah Abbas Al-Temaimi, Sindhu Jacob, Waleed Al-Ali, Diana Ann Thomas, Fahd Al-Mulla. Reduced FHIT Expression Is Associated with Mismatch Repair Deficient and High CpG Island Methylator Phenotype Colorectal CancerJournal of Histochemistry & Cytochemistry 2013; 61(9): 627 doi: 10.1369/0022155413497367
8
Mark Bloomston, Jeffrey Kneile, Matthew Butterfield, Mary Dillhoff, Peter Muscarella, E. Christopher Ellison, W. Scott Melvin, Carlo M. Croce, Flavia Pichiorri, Kay Huebner, Wendy L. Frankel. Coordinate Loss of Fragile Gene Expression in Pancreatobiliary Cancers: Correlations Among Markers and Clinical FeaturesAnnals of Surgical Oncology 2009; 16(8): 2331 doi: 10.1245/s10434-009-0507-4
9
Qi‑Biao Su, Lai‑You Wang, Gui‑Ning Wei, Li‑Zhen Liao, Jie Zhao, Hong‑Jun Liu, Yu‑Long Shi, Le‑Ping Li, Chen‑Sheng Li. Livin serves as a prognostic marker for mid‑distal rectal cancer and a target of mid‑distal rectal cancer treatmentOncology Letters 2017;  doi: 10.3892/ol.2017.7230